Monograph
C07AG01 - Labetalol |
Not porphyrinogenic |
NP |
Rationale
Alpha/beta-blocker. Several references stating non-porphyrinogenicity. Alpha/beta receptor blocker of choice in acute porphyria.
Chemical description
Alpha/beta - receptor blocking agent. Metabolized by CYP 2D6 dependent conjugation to glucuronide, excreted in urine and bile.Some oxidative metabolism may take place but a minor pathway. Less than 5% excreted in unchanged form in urine. Thunell, patient report (n=1): tolerated. Andersson, patient report (n=1): tolerated. South African list: use. French list: authorized. Kalman, Bonkowsky: believed to be safe. Michael Moore's list: safe. Moore MR, Hift RJ: Drugs in the acute porphyrias. Cell Mol Biol. 43:89, 1997: safe.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Labetalol HCl Mylan 100 mg, tabletten · Labetalol HCl Mylan 200 mg, tabletten · Labetalol HCl Mylan 400 mg, tabletten · Trandate Injectie, 5 mg/ml oplossing voor injectie of concentraat voor oplossing voor infusie · Trandate Injectie, oplossing voor injectie 5 mg/ml · Trandate Injectie, oplossing voor injectie of concentraat voor oplossing voor infusie 5 mg/ml 
Trandate 100 mg compr. pellic. · Trandate 200 mg compr. pellic. · Trandate 5 mg/ml sol. inj. i.v. amp. 
Labetalol · Trandate · TRANDATE 100 mg, COMPRIMIDOS RECUBIERTOS · TRANDATE 200 mg COMPRIMIDOS RECUBIERTOS · TRANDATE 5 mg/ml SOLUCI?N INYECTABLE 
Trandate 
TRANDATE 5 mg/ml 
Labetalol · Trandate 
Labetalol S.A.L.F. · Trandate 
Labetalol S.A.L.F. · Trandate 
Trandate 
Trandate 
Albetol · Labetalol S.A.L.F.
© NAPOS 2025